Fieldview Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Fieldview Capital Management's HALO Position: Q3 2026 in Review
Fieldview Capital Management sold out of Halozyme (HALO) in Q3 2026, closing a stake of 2,878 shares — an estimated $225K sold.
Fieldview Capital Management first reported a position in HALO in Q3 2025 and held it in 2 quarters. The position peaked at $785K in Q3 2025. 768 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Fieldview Capital Management reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
- Fieldview Capital Management sold 2,878 Halozyme shares in Q3 2026, an estimated $225K.
- Fieldview Capital Management first reported a position in Halozyme in Q3 2025 and held it in 2 quarters.
- Fieldview Capital Management's Halozyme position peaked at $785K in Q3 2025.
- 768 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Fieldview Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.